• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 317/46 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Patent holdings for IPC class C07D 317/46

Total number of patents in this class: 185

10-year publication summary

22
15
19
10
15
12
11
16
9
7
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Autifony Therapeutics Limited
51
11
Arbutus Biopharma Corporation
161
9
BASF SE
21308
7
Vertex Pharmaceuticals Incorporated
1578
7
Shenyang Sinochem Agrochemicals R&D Co., Ltd.
108
6
CHDI Foundation, Inc.
107
5
Jiangsu Yangnong Chemical Co., Ltd.
66
5
H. Lundbeck A/S
1232
5
Biosplice Therapeutics, Inc.
160
5
Bristol-myers Squibb Company
4751
4
The Scripps Research Institute
1340
4
Syngenta Crop Protection AG
6710
3
JSR Corporation
2558
3
SRF Limited
51
3
LG Chem, Ltd.
17929
2
Allergan, Inc.
2162
2
Abbvie Inc.
1824
2
Brock University
58
2
Firmenich SA
1761
2
Flexus Biosciences, Inc.
13
2
Other owners 96